Vanguard Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRWD
Vanguard Capital Management's IRWD Position: Q3 2026 in Review
Vanguard Capital Management increased its Ironwood Pharmaceuticals (IRWD) stake by 0.4% in Q3 2026, buying an estimated $110K and bringing the position to 6,634,751 shares worth $26.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2249.
Vanguard Capital Management first reported a position in IRWD in Q1 2026 and has held it in 3 quarters since. The position peaked at $27.8M in Q2 2026. 233 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.
- Vanguard Capital Management held 6,634,751 shares of Ironwood Pharmaceuticals worth $26.3M as of Q3 2026.
- Vanguard Capital Management bought 26,243 Ironwood Pharmaceuticals shares in Q3 2026, an estimated $110K.
- Ironwood Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2249 holding.
- Vanguard Capital Management first reported a position in Ironwood Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Ironwood Pharmaceuticals position peaked at $27.8M in Q2 2026.
- 233 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.